Analyst Ratings for Tobira Therapeutics (TBRA)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
9/21/2016 | Cantor Fitzgerald | N/A | Downgrade | Neutral (Overweight) |
42.00 (19.00) |
38.91 (42.09) |
8.17% | Details |
4/11/2016 | H.C. Wainwright » Updated 8/10/2016 |
N/A | New Coverage | Buy (N/A) |
31.00 (22.00) |
7.30 (42.09) |
476.58% | Details |